OPHTHAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ophthaine, and when can generic versions of Ophthaine launch?
Ophthaine is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in OPHTHAINE is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ophthaine
A generic version of OPHTHAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.
Summary for OPHTHAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Patent Applications: | 4,138 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPHTHAINE at DailyMed |
US Patents and Regulatory Information for OPHTHAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | OPHTHAINE | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 008883-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |